25.09 07:00 | BUSINESS WIRE: EADV 2024 Late Breaking News Sessions: New Galderma Data Demonstrating Nemolizumab’s Long-term Efficacy and Safety in Atopic Dermatitis and Durability in Prurigo Nodularis to Be Shared During Three Oral Presentations |
17.09 07:00 | BUSINESS WIRE: Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024 |
05.09 17:42 | Aktien Schweiz schwächer - Konjunkturskepsis belastet Kurse |
05.09 09:16 | dpa-AFX: *BERENBERG STARTS GALDERMA WITH 'BUY' - PRICE TARGET 104.40 SFR |
05.09 09:16 | dpa-AFX: *BERENBERG STARTET GALDERMA MIT 'BUY' - ZIEL 104,40 CHF |
04.09 17:40 | Aktien Schweiz schwach - Logitech und Richemont unter Druck |
29.08 07:00 | BUSINESS WIRE: Galderma Successfully Issued an Inaugural CHF 500 Million Bond |
13.08 17:40 | Aktien Schweiz gut behauptet - Tecan-Aktie unter Druck |
13.08 07:01 | BUSINESS WIRE: Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis |
12.08 17:39 | dpa-AFX: *RBC STARTET GALDERMA MIT 'OUTPERFORM' - ZIEL 89 CHF |
12.08 17:39 | dpa-AFX: *RBC STARTS GALDERMA WITH 'OUTPERFORM' - PRICE TARGET 89 SFR |
06.08 17:46 | Aktien Schweiz knapp behauptet - Erholungsansatz bleibt aus |
05.08 17:44 | Aktien Schweiz erneut schwach - SMI schließt klar über Tagestief |
05.08 08:13 | L'Oreal steigt mit 10% bei Schweizer Hautpflegemarke Galderma ein |
05.08 07:20 | BUSINESS WIRE: Galderma to pursue a new scientific partnership with L’Oréal to further advance its category leadership in dermatology |
30.07 07:00 | BUSINESS WIRE: Galderma’s Relfydess™ (RelabotulinumtoxinA) Receives Positive Decision for Use in Europe |
25.07 07:00 | BUSINESS WIRE: Galderma Delivers Record Net Sales of 2.2 Billion USD and 10.8% Year-on-Year Growth at Constant Currency for the First Half of 2024 |
25.07 06:30 | BUSINESS WIRE: PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma’s Nemolizumab Improves Key Aspects of Atopic Dermatitis – Itch, Skin Lesions and Sleep Disturbance |
11.07 06:20 | ÜBERBLICK/Anstehende Indexänderungen |
24.06 06:20 | ÜBERBLICK/Anstehende Indexänderungen |
|